Amerisource Recalls Mispackaged Amphetamine Tablets Due to Unit Dose Errors
Amerisource Health Services is recalling 2,276 cartons of 10 mg amphetamine tablets because blister cavities may contain more than one tablet.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II, and the hazard involves a controlled substance (Schedule II) where mispackaging can lead to significant injury or overdose.
Plain-English summary
Amerisource Health Services is recalling 2,276 cartons of Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product) CII 10 mg. The affected product is packaged and distributed by American Health Packaging, Columbus, OH, and is identified by NDC 68084-936-25 (Carton) and NDC 68084-936-95 (Blister). The recall covers Lot 150130 (exp. 10/31/16) and Lot 161296 (exp. 8/31/17).
The recall was initiated due to unit dose mispackaging, where blister cavities may contain more than one tablet. This defect poses a risk of medication overdose if the product is administered as intended. The product was distributed nationwide.
Healthcare providers and pharmacies should stop using the affected product and contact Amerisource Health Services for instructions on returning or disposing of the stock. Patients should consult their healthcare provider if they have received or used the affected medication.
The recalled product
- Product
- Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product) CII 10 mg, 30 UD Tablets (5 x 6), Rx, Packaged and Distributed by: American Health Packaging, Columbus,
- Manufacturer
- Amerisource Health Services
- Category
- Drug — Controlled Substance
- Hazard
- Affected units
- 2,276
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot 150130
- exp. 10/31/16 and lot 161296
- exp. 8/31/17
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 10 recalled by Amerisource Health Services under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 10 products in this recall →Related recalls
Same manufacturer · Amerisource Health Services
See all →- HighAmerisource Recalls Paroxetine Tablets Due to Foreign Object Presence
FDA (Drugs) · 2017-11-29
- LowAmerisource Recalls Enalapril Maleate Tablets Due to Stability Failures
FDA (Drugs) · 2017-11-22
- ModerateAmerisource Recalls Glipizide Extended-Release Tablets Due to Dissolution Failure
FDA (Drugs) · 2017-03-22
- ModerateCyclosporine Capsules Recalled for Impurity Specification Failures
FDA (Drugs) · 2017-03-08
- ModerateAHP Nifedipine Capsules Recalled for Presence of Foreign Tablets
FDA (Drugs) · 2016-11-30
Same hazard · mispackaging
See all →- HighRitz peanut butter cracker sandwiches recalled over undeclared peanut from mispackaging
FDA (Devices) · 2025-12-31
- HighCasa Mamita churro bites recalled after cheese stick found in bag
FDA (Food) · 2025-08-06
- HighRitz peanut butter cracker 20 count cartons recalled over undeclared peanut
FDA (Food) · 2025-07-30
- HighRitz peanut butter cracker 40 count cartons recalled over undeclared peanut
FDA (Food) · 2025-07-30
- HighRitz cracker sandwich variety packs recalled over undeclared peanut from mispackaging
FDA (Food) · 2025-07-30